Research programme: anticancer camptothecin analogues - Indena
Alternative Names: IDN-5174Latest Information Update: 16 Jul 2016
At a glance
- Originator Indena
- Class Antineoplastics
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Italy (IV)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Italy (PO)